Skip to content
  1. Home
  2. Supplements
  3. Melatonin

Melatonin

A circadian-clock hormone taken most often for jet lag and sleep timing.

Supplements

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Melatonin

A circadian-clock hormone taken most often for jet lag and sleep timing.

Evidence category: Systematic review. This describes the source category, not approval or certainty.

Regulatory statement in source: Not separately recorded; do not infer approval from the evidence category.

Melatonin is a hormone produced by the pineal gland that helps regulate the body's internal circadian clock in response to darkness. Synthetic melatonin is sold as an over-the-counter dietary supplement in the United States, while several other countries regulate it as a prescription medicine, and it has been studied most extensively for jet lag and circadian sleep-timing disorders.

Benefits reported in the imported source

  • Reduces jet lag symptoms after long eastward flights in the majority of trials reviewed
  • Shortens time to sleep onset in circadian sleep-timing disorders
  • Short-term use shows a low rate of side effects across trial populations

Risks and limits

  • Long-term safety data are limited
  • Independent testing has found product content varying from label claims
  • Case reports describe interactions in people with epilepsy or on warfarin

Source bottom line: Evidence for jet lag is unusually strong for a supplement, resting on multiple randomized trials, while evidence for chronic insomnia remains weak by comparison.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

Airline passengers, airline staff and military personnel crossing five or more time zones, pooled across ten randomized trials

Reported regimen
Oral melatonin doses between 0.5 mg and 5 mg administered close to target bedtime at the destination (22:00 to midnight); doses above 5 mg showed no added benefit and a 2 mg slow-release formulation was less effective
Duration
Single doses taken near destination bedtime, pooled across ten trials
Reported outcome
Nine of ten trials found reduced jet lag symptoms after flights crossing five or more time zones, with a calculated number needed to treat of two; side effects were infrequent
Source
Melatonin for preventing and treating jet lag - Cochrane Database of Systematic Reviews (PubMed)
Claim provenance

evidence.json#/catalog:supplement:melatonin/protocols/0

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

Historical research outcome: no-verified-description · 2026-10-06

No suitable community description was independently verified in these checks. The entry remains empty; this does not establish that no practice exists elsewhere.

Pharmacokinetic context

Historical half-life estimate: 0.9 hours. Andersen et al. 2016, BMC Pharmacol Toxicol, PMID 26893170 — immediate-release oral, 10 mg dose; ranges 40-104 min depending on formulation and physiological state Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

Snapshot provenance

Source ID: catalog:supplement:melatonin. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.

Related entries and components

None listed.